Elixirgen Therapeutics, Inc. announced it raised $5.01 Million in an initial filing from an offering of $5.01 Million
Elixirgen Therapeutics, Inc. announced it raised $5.01 Million in an initial filing from an offering of $5.01 Million
12/02/19, 8:41 PM
Location
baltimoreMoney raised
$5.01 million
Industry
biotechnology
Company Info
Location
855 n. wolfe st.
baltimore, maryland, united states
Additional Info
Elixirgen Therapeutics is a biotechnology company advancing its controllable self-replicating RNA technology to develop therapies for a broad spectrum of diseases, including rare diseases, aging-related disorders, and cancer. Elixirgen Therapeutics is located in the Science + Technology Park at Johns Hopkins in Baltimore.